HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Medication-adherent first-episode psychosis patients also relapse: why?

AbstractOBJECTIVE:
Poor adherence to medication is a major determinant of relapse following treatment of first-episode psychosis (FEP). However, medication-adherent patients also relapse. We examined what factors influence the risk of relapse after controlling for adherence.
METHOD:
We selected a sample of fully adherent patients (n = 65) who had achieved remission at one point. We then compared patients who relapsed, using 2 different definitions of relapse, to those who did not relapse by 12 months on age, sex, premorbid adjustment, duration of untreated psychosis, length of prodrome, and substance abuse.
RESULTS:
Among the 65 medication-adherent patients in remission, 9 (14%) relapsed according to criteria for relapse requiring a change in medication. These patients differed from those who remained in remission only in the pattern of premorbid adjustment (greater proportion with deteriorating pattern), although this was not independent of other variables. No differences were found on any other variable. Using a more commonly used metric for relapse, based on symptom ratings alone, an additional 14 (21.5%) patients relapsed. Substance abuse significantly predicted relapse, with substance abusers having more than 25 times the odds of relapsing by 12 months (OR 25.6; 95% CI 2.4 to 278.1, P = 0.008).
CONCLUSION:
Using a more conservative definition of relapse in this adherent-to-medication population, we find a very low rate of relapse associated, at least partially, with poor premorbid adjustment. As substance abuse was a significant predictor of symptomatic relapse, this would suggest that there should be a greater emphasis on interventions focused on reducing substance abuse in FEP.
AuthorsEmmanuelle Levy, Nicole Pawliuk, Ridha Joober, Sherezad Abadi, Ashok Malla
JournalCanadian journal of psychiatry. Revue canadienne de psychiatrie (Can J Psychiatry) Vol. 57 Issue 2 Pg. 78-84 (Feb 2012) ISSN: 1497-0015 [Electronic] United States
PMID22340147 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
Topics
  • Adolescent
  • Adult
  • Antipsychotic Agents (therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Logistic Models
  • Male
  • Medication Adherence
  • Psychotic Disorders (diagnosis, drug therapy)
  • Recurrence
  • Risk Factors
  • Substance-Related Disorders

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: